1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited

TORNTPHARM.BO
Torrent Pharmaceuticals LimitedIN flagBombay Stock Exchange
4,369.50
INR
+55.25
- -
1.48TMarket Cap

Total Valuation

Torrent Pharmaceuticals Limited carries a market capitalization of 1.48T, placing it among publicly traded companies globally. Its enterprise value stands at 1.65T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.48T
Enterprise Value1.65T

Share Statistics

Torrent Pharmaceuticals Limited currently has 338.45M shares outstanding.

Shares Outstanding338.45M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Torrent Pharmaceuticals Limited trades at a trailing price-to-earnings ratio of 66.02. The price-to-sales ratio is 10.38, and the price-to-book ratio stands at 843.88.

PE Ratio66.02
PS Ratio10.38
PB Ratio843.88
P/TBV Ratio-13.14
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Torrent Pharmaceuticals Limited trades at an EV/EBITDA multiple of 47.87 and an EV/FCF ratio of 574.57. The EV/Sales ratio of 11.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 47.87 provides insight into valuation relative to core operating earnings.

EV / Sales11.97
EV / EBITDA47.87
EV / EBIT47.87
EV / FCF574.57

Financial Position

Torrent Pharmaceuticals Limited maintains a current ratio of 1.13, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 85.45, indicating elevated leverage, while an interest coverage ratio of 8.94 demonstrates adequate ability to service its debt obligations.

Current Ratio1.13
Quick Ratio0.28
Debt / Equity85.45
Debt / EBITDA4.37
Interest Coverage8.94

Financial Efficiency

Torrent Pharmaceuticals Limited posts a return on equity of 1,278.14 and a return on invested capital of 11.76.

Return on Equity (ROE)1,278.14
Return on Assets (ROA)7.29
Return on Invested Capital (ROIC)11.76
Return on Capital Employed (ROCE)17.83
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.19

Taxes

Over the trailing twelve months, Torrent Pharmaceuticals Limited has paid 7.34B in income taxes, reflecting an effective tax rate of 25.56.

Income Tax7.34B
Effective Tax Rate25.56

Stock Price Statistics

Torrent Pharmaceuticals Limited's stock has gained approximately 39.398% over the past 52 weeks. The 50-day moving average sits at 3,873.12, while the 200-day moving average is 3,568.50.

Beta (5Y)N/A
52-Week Price Change39.398%
50-Day Moving Average3,873.12
200-Day Moving Average3,568.50
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Torrent Pharmaceuticals Limited generated 137.53B in revenue and converted that into 21.63B in net income, yielding earnings per share of 63.19. EBITDA reached 34.40B, while operating income came in at 34.40B.

Revenue137.53B
Gross Profit103.65B
Operating Income34.40B
Pretax Income28.72B
Net Income21.63B
EBITDA34.40B
EBIT34.40B
Earnings Per Share (EPS)63.19

Balance Sheet

Torrent Pharmaceuticals Limited holds 23.55B in cash and equivalents against 150.26B in total debt, resulting in a net debt position of 136.81B. Total book value stands at 1.69B, with working capital of 10.49B providing operational flexibility.

Cash & Cash Equivalents23.55B
Total Debt150.26B
Net Debt136.81B
Equity (Book Value)1.69B
Book Value Per Share5.00
Working Capital10.49B

Margins

Torrent Pharmaceuticals Limited operates with a gross margin of 75.37, reflecting its pricing power and cost economics. The operating margin of 25.01 and net profit margin of 15.73 provide insight into operational efficiency.

Gross Margin75.37
Operating Margin25.01
Pretax Margin20.88
Profit Margin15.73
EBITDA Margin25.01

Stock Splits

Torrent Pharmaceuticals Limited's most recent stock split took place on July 8, 2022 with a 1:2 split ratio.

Last Split Date7/8/2022
Split Ratio1:2

Scores

Torrent Pharmaceuticals Limited posts an Altman Z-Score of 4.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.87